We are live on ! Find out more
TTNP

Titan Pharmaceuticals
TTNP

Delisted

TTNP was delisted on the 1st of October, 2025.

Back to rankings

16 hedge funds and large institutions have $88.5K invested in Titan Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.69% less ownership

Funds ownership: 3.54% → 1.85% (-1.7%)

11% less funds holding

Funds holding: 18 → 16 (-2)

51% less capital invested

Capital invested by funds: $179K → $88.5K (-$90.8K)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
16
Holders Change
-2
Holders Change %
-11.11%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$63.5K
2
UBS Group
UBS Group
Switzerland
+$27.4K
3
TRCT
Tower Research Capital (TRC)
New York
+$149
4
Morgan Stanley
Morgan Stanley
New York
+$6

Top Sellers

Rank Fund Capital Flow
1
Truist Financial
Truist Financial
North Carolina
-$174K
2
NA
NewEdge Advisors
Louisiana
-$6
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$5
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$58.3K +$63.5K +11,066 New
UBS Group
2
UBS Group
Switzerland
$25.2K +$27.4K +4,772 +477,200%
TRCT
3
Tower Research Capital (TRC)
New York
$3.92K +$149 +26 +4%
MA
4
MCF Advisors
Kentucky
$870 – – –
Bank of America
5
Bank of America
North Carolina
$89 – – –
Group One Trading
6
Group One Trading
Illinois
$64 – – –
Osaic Holdings
7
Osaic Holdings
Arizona
$52 – – –
Morgan Stanley
8
Morgan Stanley
New York
$21 +$6 +1 +33%
GWSA
9
Global Wealth Strategies & Associates
Colorado
$11 – – –
NRG
10
Nemes Rush Group
Michigan
$7 – – –
CSC
11
Caldwell Sutter Capital
California
$5 – – –
CIA
12
Cape Investment Advisory
Georgia
$5 – – –
DJSG
13
D.J. St. Germain
Massachusetts
$5 – – –
RA
14
Ransom Advisory
Rhode Island
$5 – – –
Wells Fargo
15
Wells Fargo
California
$5 – – –
WIM
16
Westside Investment Management
California
$5 – – –
Truist Financial
17
Truist Financial
North Carolina
– -$174K -31,255 Closed
Fidelity Investments
18
Fidelity Investments
Massachusetts
– -$5 -1 Closed
NA
19
NewEdge Advisors
Louisiana
– -$6 -1 Closed

TTNP Hedge Fund Activity: Q3 2024 in Review

16 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Titan Pharmaceuticals (TTNP) for Q3 2024, worth a combined $88.5K — down 51% from $179K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of TTNP and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 3 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $63.5K. The largest seller was Truist Financial, exiting entirely with an estimated $174K sold.

  • 16 institutional investors held Titan Pharmaceuticals (TTNP) as of Q3 2024, down from 18 in Q2 2024.
  • Funds reported $88.5K of Titan Pharmaceuticals stock for Q3 2024, down 51% quarter-over-quarter.
  • 1 fund opened new Titan Pharmaceuticals positions in Q3 2024 and 3 closed out, a net change of -2 holders.
  • The largest Titan Pharmaceuticals buyer in Q3 2024 was Renaissance Technologies, an estimated $63.5K added.
  • The largest Titan Pharmaceuticals seller in Q3 2024 was Truist Financial, an estimated $174K sold.

Based on aggregated 13F filings for Q3 2024.